Skip to main content
MedPacto, Inc. logo

MedPacto, Inc. — Investor Relations & Filings

Ticker · 235980 ISIN · KR7235980000 KO Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2023-10-24 Director's Dealing
Country KR South Korea
Listing KO 235980

About MedPacto, Inc.

http://www.medpacto.com/eng/

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (증권선물위원회) and the Korea Exchange. This type of filing is a standard regulatory requirement for insiders or major shareholders to disclose changes in their holdings. In the context of the provided categories, this falls under 'Director's Dealing' (DIRS), which covers reports of share transactions by company directors, executives, and major shareholders.
2023-10-24 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/KRX). This type of filing is specifically used to report insider transactions or changes in share ownership by company directors and major shareholders. According to the provided definitions, this falls under 'Director's Dealing' (DIRS).
2023-10-24 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/Korea Exchange). This type of filing is a mandatory disclosure of insider share transactions or changes in holdings by company directors and executives. According to the provided definitions, this falls under 'Director's Dealing' (DIRS).
2023-10-24 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/KRX). It details the acquisition of stock warrants by an executive (Kim Min Woo) of MedPacto. This type of filing, which reports personal share-related transactions by company insiders, is classified as 'Director's Dealing' (DIRS).
2023-10-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and the purpose of holding (influencing management) for MedPacto. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-10-13 Korean
[기재정정]증권신고서(지분증권) (2023.12)
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) filed by MedPacto. It details amendments (정정신고) to a previously filed registration statement regarding a capital increase (rights offering) and the sale of existing shares by a major shareholder. This type of regulatory filing, which provides detailed information about securities issuance, capital structure changes, and associated risks, falls under the 'Regulatory Filings' category as it is a formal submission to the financial regulator (DART/FSS).
2023-10-11 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.